TNON
Tenon Medical, Inc.
There isn't enough reported data to score TNON yet.
TNON Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Weak | |
| Unavailable |
TNON's revenue is currently strong, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
TNON PE Valuation
TNON has no meaningful PE right now: it lost money over the past year.
TNON Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect TNON's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
TNON Earnings Per Share
TNON Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $1.3M | +127% |
| Q1 2026 | $1.4M | +90% |
| Q4 2025 | $1.5M | +92% |
| Q3 2025 | $1.2M | +32% |
| Q2 2025 | $564K | -37% |
| Q1 2025 | $726K | +1% |
| Q4 2024 | $770K | -4.7% |
| Q3 2024 | $887K | -6% |
TNON's revenue has grown year over year for four quarters in a row: $1M last quarter, up 127% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -262% | +244 points |
| Q1 2026 | -238% | +269 points |
| Q4 2025 | -194% | +219 points |
| Q3 2025 | -289% | +73 points |
| Q2 2025 | -507% | -77 points |
| Q1 2025 | -506% | -19 points |
| Q4 2024 | -412% | -23 points |
| Q3 2024 | -362% | -4.6 points |
TNON's operating margin was −262% last quarter, up 244 points from the same quarter a year ago.
TNON Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$2.4M | +$324K |
| Q3 2025 | -$3.7M | -$1.3M |
| Q4 2024 | -$2.7M | -$370K |
| Q3 2024 | -$2.4M | +$763K |
| Q2 2024 | -$2.4M | +$884K |
| Q1 2024 | -$2.5M | +$1.2M |
| Q4 2023 | -$2.4M | +$1.6M |
| Q3 2023 | -$3.2M | +$280K |
TNON has burned cash in almost every quarter: −$12M over the past year, against −$10M the year before.
TNON Total Shares
TNON Net Leverage
TNON's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
TNON Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 29.2 | Oversold |
| Stochastic | 0.6 | Oversold |
TNON's weekly RSI is 29 (oversold) and its Stochastic is 1 (oversold).
TNON PE vs Healthcare Sector
TNON has no meaningful PE right now: it lost money over the past year.
TNON Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.58 | 31% below |
| 20 week MA | $4.73 | 62% below |
| 50 week MA | $18.8 | 90% below |
| 100 week MA | $32.1 | 94% below |
| 200 week MA | $685.8 | 100% below |
TNON is in a downtrend: it's below all five of its weekly moving averages, and 100% below its 200-week average.
TNON Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $60,508.0 | $4,872.0 | -92% |
| 2023 | $4,872.0 | $442.4 | -91% |
| 2024 | $442.4 | $63.4 | -86% |
| 2025 | $63.4 | $37.5 | -41% |
| 2026 YTD | $37.5 | $1.79 | -95% |
TNON has finished every year since 2022 lower, and it's down 95% so far in 2026.